S100B and Alzheimer disease: These findings suggest that S100B directly induces degenerative changes in axons and promotes the growth of degenerative axons overexpressing APP in diffuse amyloid deposits, as well as transforming benign diffuse deposits into diagnostic axonal plaques responsible for cortical atrophy in AD.